ADORA1 and breast carcinoma: ADORA1 is involved in promoting tumor growth through bone marrow-derived suppressor cells and has been reported to support tumor growth outcomes in colorectal adenocarcinoma, human leukemia Jurkat cells, breast cancer and kidney cancer.